Surya P Singh

Employment

• University of Oklahoma Health Sciences Center Postdoctoral
  2022 - Present

Education

• Banaras Hindu University Phd

Projects & Funding

Projects & funding information is unavailable.

Publications (19)

• Galactokinase 1 Inhibition-Induced Cell Cycle Arrest and Apoptosis in Bladder Cancer Cells Is Associated with AKT Signaling Downregulation
  International Journal of Molecular Sciences 2026 DOI: 10.3390/ijms27062911
  +Save
• Chromatin Remodulator CHD4: A Potential Target for Cancer Interception
  Genes 2025 DOI: 10.3390/genes16020225
  +Save
• Targeting Thyroid Hormone Receptor Interacting Protein (TRIP13) for Cancer Therapy: A Promising Approach
  DNA 2025 DOI: 10.3390/dna5010003
  +Save
• Correction to: Stat3 Inhibitors TTI-101 and SH5-07 Suppress Bladder Cancer Cell Survival in 3D Tumor Models (Cells, (2024), 13, 17, (1463), 10.3390/cells13171463)
  Cells 2025 DOI: 10.3390/cells14040299
  +Save
• Stat3 Inhibitors TTI-101 and SH5-07 Suppress Bladder Cancer Cell Survival in 3D Tumor Models
  Cells 2024 DOI: 10.3390/cells13171463
  +Save
• Abstract 506: TRIP13 is a promising therapeutic target for bladder cancer
  Cancer Research 2024 DOI: 10.1158/1538-7445.am2024-506
  +Save
• Abstract 7299: Preventing CRC progression in FAP rat model using a combinational targeting of TRAIL signaling and inflammation
  Cancer Research 2024 DOI: 10.1158/1538-7445.am2024-7299
  +Save
• Synthesized Gold Nanoparticles with Moringa Oleifera leaf Extract Induce Mitotic Arrest (G2/M phase) and Apoptosis in Dalton’s Lymphoma Cells
  Cell Biochemistry and Biophysics 2024 DOI: 10.1007/s12013-024-01257-1
  +Save
• Abstract 5260: Chemopreventive efficacy of everolimus and naproxen combination against carcinogen induced bladder cancer in F344 rats
  Cancer Research 2023 DOI: 10.1158/1538-7445.am2023-5260
  +Save
• Bladder Cancer Prevention: Potential Molecular Targets and Their Clinically Relevant Agents
  Current Pharmacology Reports 2023 DOI: 10.1007/s40495-023-00326-y
  +Save